Clinical trials in Unterhaching

Innovative clinical trials focusing on relapsing-remitting multiple sclerosis are evaluating new therapeutic approaches. Studies include comparative analyses of novel treatments and established medications like ocrelizumab, examining both clinical effectiveness and safety profiles.

• Pharmacokinetic comparisons
• Brain lesion suppression assessment
• Combined therapy evaluations

Research includes advanced MRI monitoring of CNS inflammation and innovative combination therapies.

Comprehensive research into chronic and episodic migraine prevention, with trials examining the efficacy of novel oral medications. Studies are comparing different treatment approaches to establish optimal preventive strategies.

• Long-term safety assessments
• Comparative tolerability studies
• Prevention protocol evaluation

Extended 156-week trials are underway to evaluate sustained effectiveness in migraine prevention.

Groundbreaking research examining acute migraine interventions through randomized, controlled trials. Studies focus on evaluating new therapeutic options for immediate migraine relief.

• Single-attack efficacy analysis
• Multiple-attack assessment
• Treatment consistency evaluation

Trials include both double-blind and open-label extension phases to ensure comprehensive safety and efficacy data.